You are here

Hike in medication price leads to drop in demand

As expenses mount, patients will look for alternatives, no matter how popular or useful the product

meds.jpg
Early last year, drugmaker Mallinckrodt plc spent US$1.3 billion to buy a company that sold an injectable form of acetaminophen - essentially Tylenol in a liquid solution.

New York

EARLY last year, drugmaker Mallinckrodt plc spent US$1.3 billion to buy a company that sold an injectable form of acetaminophen - essentially Tylenol in a liquid solution.

Within months, the new owner more than doubled the price of the drug, called Ofirmev. Revenue from

sentifi.com

Market voices on:

Powered by GET.comGetCom